Prediction of intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke using multiple artificial neural networks

Neurological Research

Volumn 34, Issue 2, 2012, Pages 120-128

  Dharmasaroja, Permphan ^a   Dharmasaroja, Pornpatr A ^b  

^a Mahidol University ^*  (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

ANN analysis; Plasminogen activator; ROC curve; rtPA; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FIBRINOLYTIC THERAPY; INTERNATIONAL NORMALIZED RATIO; PERCEPTRON; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SUPPORT VECTOR MACHINE;

AREA UNDER CURVE; CEREBRAL HEMORRHAGE; HUMANS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STROKE; SUPPORT VECTOR MACHINES; THROMBOLYTIC THERAPY;

EID: 84857943340     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132811Y.0000000067     Document Type: Article

References (48)

1. Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Siddiqui M, Alvarez-Sabín J, et al. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Neurology 2008;71:1304-12.
2. Marti-Fabregas J, Bravo Y, Cocho D, Martí-Vilalta JL, Díaz-Manera J, San Román L, et al. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials. Cerebrovasc Dis 2007;23:85-90.
3. Tsivgoulis G, Frey JL, Flaster M, Sharma VK, Lao AY, Hoover SL, et al. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage. Stroke 2009;40:3631-4.
4. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007;24:1-10.
5. Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry 2008;79:1093-9.
6. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438-41.
7. IMS study investigators. Hemorrhage in the Interventional Management of Stroke study. Stroke 2006;37:847-51.
8. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002; 105:1679-85.
9. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. Can Med Assoc J 2005;172:1307-12.
10. Cocho D, Borrell M, Marti-Fabregas J, Montaner J, Castellanos M, Bravo Y, et al. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Stroke 2006;37:996-9.
11. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-18.
12. Dubey N, Bakshi R, Wasay M, Dmochowski J. Early computed tomography hypodensity predicts hemorrhage after intravenous tissue plasminogen activator in acute ischemic stroke. J Neuroimaging 2001;11:184-8.
13. Gilligan AK, Markus R, Read S, Srikanth V, Hirano T, Fitt G, et al. Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke. Stroke 2002;33:2236-42.
14. Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, et al. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. Stroke 2004;35:2123-7.
15. Yamamura S. Clinical application of artificial neural network (ANN) modeling to predict pharmacokinetic parameters of severely ill patients. Adv Drug Deliv Rev 2003;55:1233-51.
16. Valdes JJ, Bonham-Carter G. Time dependent neural network models for detecting changes of state in complex processes: applications in earth sciences and astronomy. Neural Netw 2006;19:196-207.
17. Alshekhlee A, Mohammadi A, Mehta S, Edgell RC, Vora N, Feen E, et al. Is thrombolysis safe in the elderly?: analysis of a national database. Stroke 2010;41:2259-64.
18. Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, et al. Pretreatment ASPECTS on DWI predicts 3- month outcome following rt-PA: SAMURAI rt-PA Registry. Neurology 2010;75:555-61.
19. Aries MJ, Uyttenboogaart M, Vroomen PC, De Keyser J, Luijckx GJ. tPA treatment for acute ischaemic stroke in patients with leukoaraiosis. Eur J Neurol 2010;17:866-70.
20. Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S, et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010;41:1450-8.
21. Meurer WJ, Scott PA, Caveney AF, Majersik JJ, Frederiksen SM, Sandretto A, et al. Lack of association betweenhyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. Int J Stroke 2010;5:163-6.
22. Huang S, Shen Q, Duong TQ. Artificial neural network prediction of ischemic tissue fate in acute stroke imaging. J Cereb Blood Flow Metab 2010;30:1661-70.
23. Swiercz M, Kochanowicz J, Weigele J, Hurst R, Liebeskind DS, Mariak Z, et al. Learning vector quantization neural networks improve accuracy of transcranial color-coded duplex sonography in detection of middle cerebral artery spasm-preliminary report. Neuroinformatics 2008;6:279-90.
24. Aleksic M, Luebke T, Heckenkamp J, Gawenda M, Reichert V, Brunkwall J. Implementation of an artificial neuronal network to predict shunt necessity in carotid surgery. Ann Vasc Surg 2008;22:635-42.
25. Barnes RW, Toole JF, Nelson JJ, Howard VJ. Neural networks for ischemic stroke. J Stroke Cerebrovasc Dis 2006;15:223-7.
26. Rebrova O, Maksimova M, Piradov MA. The neural network algorithm for diagnosis of ischemic stroke pathogenetic subtypes. Zh Nevrol Psikhiatr Im S S Korsakova 2004;(Suppl 12):23-8.
27. Kemeny V, Droste DW, Hermes S, Nabavi DG, Schulte-Altedorneburg G, Siebler M, et al. Automatic embolus detection by a neural network. Stroke 1999;30:807-10.
28. Gottrup C, Thomsen K, Locht P, Wu O, Sorensen AG, Koroshetz WJ, et al. Applying instance-based techniques to prediction of final outcome in acute stroke. Artif Intell Med 2005;33:223-36.
29. Peng SY, Chuang YC, Kang TW, Tseng KH. Random forest can predict 30-day mortality of spontaneous intracerebral hemorrhage with remarkable discrimination. Eur J Neurol 2010;17:945-50.
30. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New Engl J Med 2008;359:1317-29.
31. Adams H, Adams R, Del Zoppo G, Goldstein LB, Stroke Council of the American Heart Association, American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36:916-23.
32. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4.
33. Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
34. Brott T, Adams HP, Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-70.
35. Sherrod PH. DTREG manual, 2010 [accessed 2011 February 20]. Available from: http://www.dtreg.com/DTREG.pdf.
36. Edwards DF, Hollingsworth H, Zazulia AR, Diringer MN. Artificial neural networks improve the prediction of mortality in intracerebral hemorrhage. Neurology 1999;53:351-7.
37. Kim BJ, Lee SH, Ryu WS, Kang BS, Kim CK, Yoon BW. Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke 2009;40:1627-32.
38. Bang OY, Saver JL, Liebeskind DS, Starkman S, Villablanca P, Salamon N, et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007;68:737-42.
39. Kellert L, Rocco A, Sykora M, Hacke W, Ringleb PA. Frequency of increased blood pressure levels during systemic thrombolysis and risk of intracerebral hemorrhage. Stroke 2011;42:1702-6.
40. Adams HP, Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711.
41. The National Institute of Neurological Disorders and Stroke rt- PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New Engl J Med 1995;333:1581-7.
42. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-18.
43. Das K, Giesbrecht B, Eckstein MP. Predicting variations of perceptual performance across individuals from neural activity using pattern classifiers. Neuroimage 2010;51:1425-37.
44. De Martino F, Valente G, Staeren N, Ashburner J, Goebel R, Formisano E. Combining multivariate voxel selection and support vector machines for mapping and classification of fMRI spatial patterns. Neuroimage 2008;43:44-58.
45. Haller S, Bartsch A, Nguyen D, Rodriguez C, Emch J, Gold G, et al. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. Radiology 2010;257:764-73.
46. Byvatov E, Schneider G. Support vector machine applications in bioinformatics. Appl Bioinformatics 2003;2:67-77.
47. Muniz AM, Liu H, Lyons KE, Pahwa R, Liu W, Nobre FF, et al. Comparison among probabilistic neural network, support vector machine and logistic regression for evaluating the effect of subthalamic stimulation in Parkinson disease on ground reaction force during gait. J Biomech 2010;43:720-6.
48. McQuisten KA, Peek AS. Comparing artificial neural networks, general linear models and support vector machines in building predictive models for small interfering RNAs. PLoS One 2009;4:e7522.